NKY80 is a potent, selective and non-competitive adenylyl cyclase (AC) type V isoform inhibitor with IC50s of 8.3 μM, 132 μM and 1.7 mM for type V, III and II, respectively. NKY80 is a non-nucleoside quinazolinone and regulates the AC catalytic activity in heart and lung tissues.
性状
Solid
IC50 & Target[1][2]
IC50: 8.3 μM (AC type V), 132 μM (AC type III) and 1.7 mM (AC type II)
体外研究(In Vitro)
NKY80 (20 μM) blocks the elevations in both LVP and ventricular cAMP levels produced by the maximal concentration (10 nM).
NKY80 (20 μM; 2 hours) completely blocks the increase in both cAMP content and renin release from isolated JG cells.
Medlife has not independently confirmed the accuracy of these methods. They are for reference only.